Wendy W. Verslues-Hwang

TPQ 11520, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

BMAL2 is a druggable target for ovarian clear cell carcinoma (OCCC).

BMAL2 is a druggable target for ovarian clear cell carcinoma (OCCC).

Journal: EMBO molecular medicine
Published: October 30, 2025

Core clock gene BMAL1 and RNA-binding protein MEX3A collaboratively regulate Lgr5 expression in intestinal crypt cells.

Core clock gene BMAL1 and RNA-binding protein MEX3A collaboratively regulate Lgr5 expression in intestinal crypt cells.

Journal: Scientific reports
Published: May 06, 2023

MEX3A Mediates p53 Degradation to Suppress Ferroptosis and Facilitate Ovarian Cancer Tumorigenesis.

MEX3A Mediates p53 Degradation to Suppress Ferroptosis and Facilitate Ovarian Cancer Tumorigenesis.

Journal: Cancer research
Published: April 07, 2022

Differential effects of SUMO1 and SUMO2 on circadian protein PER2 stability and function.

Differential effects of SUMO1 and SUMO2 on circadian protein PER2 stability and function.

Journal: Scientific reports
Published: February 19, 2021

Interplay between desmoglein2 and hypoxia controls metastasis in breast cancer.

Interplay between desmoglein2 and hypoxia controls metastasis in breast cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 12, 2021

Long-term exposure to extremely low-dose of nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induce non-malignant breast epithelial cell transformation through activation of the a9-nicotinic acetylcholine receptor-mediated signaling pathway.

Long-term exposure to extremely low-dose of nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induce non-malignant breast epithelial cell transformation through activation of the a9-nicotinic acetylcholine receptor-mediated signaling pathway.

Journal: Environmental toxicology
Published: June 07, 2018

Pro-inflammatory cytokines IL-6 and CCL2 suppress expression of circadian gene Period2 in mammary epithelial cells.

Pro-inflammatory cytokines IL-6 and CCL2 suppress expression of circadian gene Period2 in mammary epithelial cells.

Journal: Biochimica et biophysica acta. Gene regulatory mechanisms
Published: May 26, 2018

The impact of the effectiveness of GATA3 as a prognostic factor in breast cancer.

The impact of the effectiveness of GATA3 as a prognostic factor in breast cancer.

Journal: Human pathology
Published: February 23, 2018

A Novel Dual HDAC6 and Tubulin Inhibitor, MPT0B451, Displays Anti-tumor Ability in Human Cancer Cells in Vitro and in Vivo.

A Novel Dual HDAC6 and Tubulin Inhibitor, MPT0B451, Displays Anti-tumor Ability in Human Cancer Cells in Vitro and in Vivo.

Journal: Frontiers in pharmacology
Published: November 23, 2017

TGF-β1 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up-regulation of IL-17RB.

TGF-β1 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up-regulation of IL-17RB.

Journal: EMBO molecular medicine
Published: October 11, 2017

Stage-specific embryonic antigen-3 (SSEA-3) and β3GalT5 are cancer specific and significant markers for breast cancer stem cells.

Stage-specific embryonic antigen-3 (SSEA-3) and β3GalT5 are cancer specific and significant markers for breast cancer stem cells.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 19, 2015

Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines.

Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines.

Journal: The Journal of experimental medicine
Published: March 04, 2015
Showing 1-12 of 15

Last Updated: 09/26/2026